CN102335390B - Lotion for treating facial eczema - Google Patents
Lotion for treating facial eczema Download PDFInfo
- Publication number
- CN102335390B CN102335390B CN 201110294088 CN201110294088A CN102335390B CN 102335390 B CN102335390 B CN 102335390B CN 201110294088 CN201110294088 CN 201110294088 CN 201110294088 A CN201110294088 A CN 201110294088A CN 102335390 B CN102335390 B CN 102335390B
- Authority
- CN
- China
- Prior art keywords
- parts
- lotion
- flos
- radix
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 29
- 208000010668 atopic eczema Diseases 0.000 title claims abstract description 27
- 239000006210 lotion Substances 0.000 title claims abstract description 24
- 230000001815 facial effect Effects 0.000 title claims abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 30
- 229940079593 drug Drugs 0.000 claims abstract description 27
- 235000014375 Curcuma Nutrition 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241000628997 Flos Species 0.000 claims description 51
- 238000002360 preparation method Methods 0.000 claims description 13
- 241000605447 Anemarrhena Species 0.000 claims description 12
- 241000407170 Curcuma Species 0.000 claims description 12
- 241000245240 Lonicera Species 0.000 claims description 12
- 239000012467 final product Substances 0.000 claims description 7
- 206010040882 skin lesion Diseases 0.000 abstract description 6
- 231100000444 skin lesion Toxicity 0.000 abstract description 6
- 230000028327 secretion Effects 0.000 abstract description 5
- 230000001225 therapeutic effect Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 description 7
- 208000003251 Pruritus Diseases 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 230000035876 healing Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 238000006748 scratching Methods 0.000 description 2
- 230000002393 scratching effect Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a lotion for treating facial eczema, which is prepared from the following bulk drugs in parts by weight: 20-30 parts of radix sophorae flavescentis, 20-30 parts of honeysuckle flower, 20-30 parts of rhizoma anemarrhenae, 10-20 parts of chrysanthemum, 10-20 parts of curcuma aromatic, 10-20 parts of safflower, 5-15 parts of rhizoma atractylodis and 5-15 parts of liquorice. The lotion is prepared by the following steps of: after mixing the bulk drugs, adding water to immerse the bulk drugs, decocting for 30-60 minutes, and removing dregs of the decoction by filtration. A using method of the lotion comprises the following steps of: when treating, soaking 6-8 layers of medical gauze in the lotion, taking out and twisting till no water drops, putting on skin lesions tightly, and determining the time and the frequency for changing the gauze according to the amount of secretion. The lotion is used once each day for 2-4 treating periods with 7 days each to treat facial eczema. By using the lotion provided by the invention, 68 patients in 74 patients are cured through the several-year clinical application, and the effective rate reaches 91.9 percent. The medicament provided by the invention has the advantages of obvious therapeutic effect, instant effect, no side effect and low treating cost.
Description
Technical field
The invention provides a kind of lotion for the treatment of facial eczema dermatitis.
Background technology
Eczema is that the inflammatory skin of a kind of common epidermis that is caused by multiple internal and external factor and high dermis is sick, and its characteristics are conscious violent pruritus, and the skin lesion pleomorphism is symmetrical, and the tendency of oozing out is arranged, the chronic course of disease, easily repeatedly outbreak.The illing skin feature: can betide any position, be common in face, ear after, extremity bend side, breast, hand, scrotum etc. and locate, and are symmetrical.Can be divided into acute, subacute and chronic eczema according to the skin lesion characteristics.The three there is no obvious boundary, can the phase co-conversion.Eczema can occur in any position, and is often symmetrical.Acute stage, be apt to occur in the exposure portion such as women's head-ornaments, ear, hands, foot, forearm, shank, extends to whole body when serious; Chronic phase, be apt to occur in hands, foot, shank, the fossa cubitalis, thigh section, breast, pudendum.Although the cause of disease of eczema is very complicated, with heredity, immunity, environment, physiology, pharmacology relation is arranged all, it takes the form of and is continuous and unbroken, and this plays that and falls, and sends out from body, even can spread all over whole body, and eczema does not infect, and if prolongedly do not heal, majority can be expanded from body.
Eczema is very large to people's psychological impact, and the patient is mood agitation, anxiety often, dare not see people etc., wherein again with facial eczema for very, because of the affected part at face, the patient, particularly female patient often dare not be gone out, and dare not look in the mirror etc., have in addition cause serious mental maladjustment.
Although the medicine of multiple treatment eczema is arranged in the prior art, mostly there are deficiency or the defectives such as therapeutic effect is not good, healing rear easily recurrence, toxic side effect, treatment cost is high, treatment cycle is long,
Summary of the invention
For above-mentioned prior art, the invention provides a kind of lotion for the treatment of facial eczema, its therapeutic effect is remarkable, and non-relapse after healing has no side effect, and treatment cost is low, and treatment cycle is short.
The present invention is achieved by the following technical solutions:
A kind of lotion for the treatment of facial eczema is to be made by the crude drug of following weight portion: 20～30 parts of Radix Sophorae Flavescentiss, 20～30 parts of Flos Loniceraes, 20～30 parts of the Rhizoma Anemarrhenaes, 10～20 parts of Flos Chrysanthemis, 10～20 parts of Radix Curcumaes, 10～20 parts on Flos Carthami, 5～15 parts of Rhizoma Atractylodis, 5～15 parts in Radix Glycyrrhizae.
Preferably, be to be made by the crude drug of following weight portion: 25 parts of Radix Sophorae Flavescentiss, 25 parts of Flos Loniceraes, 25 parts of the Rhizoma Anemarrhenaes, 15 parts of Flos Chrysanthemis, 15 parts of Radix Curcumaes, 15 parts on Flos Carthami, 10 parts of Rhizoma Atractylodis, 10 parts in Radix Glycyrrhizae.
Preferably, be to be made by the crude drug of following weight portion: 22 parts of Radix Sophorae Flavescentiss, 22 parts of Flos Loniceraes, 28 parts of the Rhizoma Anemarrhenaes, 18 parts of Flos Chrysanthemis, 12 parts of Radix Curcumaes, 12 parts on Flos Carthami, 13 parts of Rhizoma Atractylodis, 13 parts in Radix Glycyrrhizae.
Preferably, be to be made by the crude drug of following weight portion: 28 parts of Radix Sophorae Flavescentiss, 28 parts of Flos Loniceraes, 22 parts of the Rhizoma Anemarrhenaes, 12 parts of Flos Chrysanthemis, 18 parts of Radix Curcumaes, 18 parts on Flos Carthami, 8 parts of Rhizoma Atractylodis, 8 parts in Radix Glycyrrhizae.
Preferably, be to be made by the crude drug of following weight portion: 20 parts of Radix Sophorae Flavescentiss, 30 parts of Flos Loniceraes, 20 parts of the Rhizoma Anemarrhenaes, 20 parts of Flos Chrysanthemis, 10 parts of Radix Curcumaes, 20 parts on Flos Carthami, 5 parts of Rhizoma Atractylodis, 15 parts in Radix Glycyrrhizae.
Preferably, be to be made by the crude drug of following weight portion: 30 parts of Radix Sophorae Flavescentiss, 20 parts of Flos Loniceraes, 30 parts of the Rhizoma Anemarrhenaes, 10 parts of Flos Chrysanthemis, 20 parts of Radix Curcumaes, 10 parts on Flos Carthami, 15 parts of Rhizoma Atractylodis, 5 parts in Radix Glycyrrhizae.
During preparation, after each crude drug mixing, add water to submerge, decoct 30～60min, remove by filter medicinal residues, and get final product.
During treatment, get 6～8 layers of hospital gauze and be dipped in the medicinal liquid, take out to be screwed onto not drip and be advisable, closely spread on the skin lesion place, and change time and the number of times of gauze according to how much deciding of secretions: gauze is cleaner, and secretions can drip the humidity that drug of topical application liquid keeps gauze when few at any time; The exudate that absorbs such as gauze has reached the semi-saturation degree and should change immediately gauze, repeatedly continues 1 hour.Cold wet compress is advisable with 18～25 ℃ of room temperatures.Need not again assistance application other medicines during treatment.Seven days courses for the treatment of, can cure general 2～4 courses for the treatment of.
Lotion of the present invention has removing toxic substances and promoting subsidence of swelling, antipruritic, the infection control of convergence, soft crust and takes off corruption, cleaning skin ulcer face, promotes the effect such as skin lesion healing.Through clinical application for many years, treat altogether patient's 74 examples, cure 68 examples, cure rate reaches 91.9%.Medicine of the present invention have therapeutic effect significantly, instant effect, have no side effect, the advantage such as treatment cost is low.
The specific embodiment
The present invention is further illustrated below in conjunction with embodiment and clinical data:
Embodiment 1: the lotion of preparation treatment facial eczema
Take by weighing the raw material of following component: Radix Sophorae Flavescentis 25 grams, Flos Lonicerae 25 grams, the Rhizoma Anemarrhenae 25 grams, Flos Chrysanthemi 15 grams, Radix Curcumae 15 grams, Flos Carthami 15 grams, Rhizoma Atractylodis 10 grams, Radix Glycyrrhizae 10 grams.
During preparation, after each crude drug mixing, add water to submerge, decoct 45min, remove by filter medicinal residues, and get final product.
Embodiment 2: the lotion of preparation treatment facial eczema
Take by weighing the raw material of following component: Radix Sophorae Flavescentis 22 grams, Flos Lonicerae 22 grams, the Rhizoma Anemarrhenae 28 grams, Flos Chrysanthemi 18 grams, Radix Curcumae 12 grams, Flos Carthami 12 grams, Rhizoma Atractylodis 13 grams, Radix Glycyrrhizae 13 grams.
During preparation, after each crude drug mixing, add water to submerge, decoct 40min, remove by filter medicinal residues, and get final product.
Embodiment 3: the lotion of preparation treatment facial eczema
Take by weighing the raw material of following component: Radix Sophorae Flavescentis 28 grams, Flos Lonicerae 28 grams, the Rhizoma Anemarrhenae 22 grams, Flos Chrysanthemi 12 grams, Radix Curcumae 18 grams, Flos Carthami 18 grams, Rhizoma Atractylodis 8 grams, Radix Glycyrrhizae 8 grams.
During preparation, after each crude drug mixing, add water to submerge, decoct 50min, remove by filter medicinal residues, and get final product.
Embodiment 4: the lotion of preparation treatment facial eczema
Radix Sophorae Flavescentis 20 grams, Flos Lonicerae 30 grams, the Rhizoma Anemarrhenae 20 grams, Flos Chrysanthemi 20 grams, Radix Curcumae 10 grams, Flos Carthami 20 grams, Rhizoma Atractylodis 5 grams, Radix Glycyrrhizae 15 grams.
During preparation, after each crude drug mixing, add water to submerge, decoct 30min, remove by filter medicinal residues, and get final product.
Embodiment 5: the lotion of preparation treatment facial eczema
Radix Sophorae Flavescentis 30 grams, Flos Lonicerae 20 grams, the Rhizoma Anemarrhenae 30 grams, Flos Chrysanthemi 10 grams, Radix Curcumae 20 grams, Flos Carthami 10 grams, Rhizoma Atractylodis 15 grams, Radix Glycyrrhizae 5 grams.
During preparation, after each crude drug mixing, add water to submerge, decoct 60min, remove by filter medicinal residues, and get final product.
Case: the patient appoints so-and-so, the woman, and 27 years old, face suffered from eczema, was the pimple shape, and pruritus is hard to bear, and erubescence after the scratching has liquid to ooze out.Mental pressure is huge, bows when seeing the people, expression in the eyes hides the emotion of feeling oneself inferior.Adopt the medicine of embodiment 1 preparation to treat, therapeutic modality: get 6～8 layers of hospital gauze and be dipped in the medicinal liquid, taking-up is screwed onto not drip and is advisable, closely spread on the skin lesion place, and change time and the number of times of gauze according to how much deciding of secretions: gauze is cleaner, and secretions can drip the humidity that drug of topical application liquid keeps gauze when few at any time; The exudate that absorbs such as gauze has reached the semi-saturation degree and should change immediately gauze, repeatedly continues 1 hour.Cold wet compress is advisable with 18～25 ℃ of room temperatures.Need not again assistance application other medicines during treatment.Seven days courses for the treatment of.After treating a course for the treatment of, pruritus becomes little itching, and no longer includes after the scratching that liquid oozes out or seldom have liquid to ooze out.After two courses for the treatment of, it is smooth that skin recovers, and the colour of skin is normal, cures.Pay a return visit after half a year, have no recurrence.
Claims (7)
1. a lotion for the treatment of facial eczema is characterized in that, is to be made by the crude drug of following weight portion: 20～30 parts of Radix Sophorae Flavescentiss, 20～30 parts of Flos Loniceraes, 20～30 parts of the Rhizoma Anemarrhenaes, 10～20 parts of Flos Chrysanthemis, 10～20 parts of Radix Curcumaes, 10～20 parts on Flos Carthami, 5～15 parts of Rhizoma Atractylodis, 5～15 parts in Radix Glycyrrhizae.
2. a kind of lotion for the treatment of facial eczema according to claim 1 is characterized in that, is to be made by the crude drug of following weight portion: 25 parts of Radix Sophorae Flavescentiss, 25 parts of Flos Loniceraes, 25 parts of the Rhizoma Anemarrhenaes, 15 parts of Flos Chrysanthemis, 15 parts of Radix Curcumaes, 15 parts on Flos Carthami, 10 parts of Rhizoma Atractylodis, 10 parts in Radix Glycyrrhizae.
3. a kind of lotion for the treatment of facial eczema according to claim 1 is characterized in that, is to be made by the crude drug of following weight portion: 22 parts of Radix Sophorae Flavescentiss, 22 parts of Flos Loniceraes, 28 parts of the Rhizoma Anemarrhenaes, 18 parts of Flos Chrysanthemis, 12 parts of Radix Curcumaes, 12 parts on Flos Carthami, 13 parts of Rhizoma Atractylodis, 13 parts in Radix Glycyrrhizae.
4. a kind of lotion for the treatment of facial eczema according to claim 1 is characterized in that, is to be made by the crude drug of following weight portion: 28 parts of Radix Sophorae Flavescentiss, 28 parts of Flos Loniceraes, 22 parts of the Rhizoma Anemarrhenaes, 12 parts of Flos Chrysanthemis, 18 parts of Radix Curcumaes, 18 parts on Flos Carthami, 8 parts of Rhizoma Atractylodis, 8 parts in Radix Glycyrrhizae.
5. a kind of lotion for the treatment of facial eczema according to claim 1 is characterized in that, is to be made by the crude drug of following weight portion: 20 parts of Radix Sophorae Flavescentiss, 30 parts of Flos Loniceraes, 20 parts of the Rhizoma Anemarrhenaes, 20 parts of Flos Chrysanthemis, 10 parts of Radix Curcumaes, 20 parts on Flos Carthami, 5 parts of Rhizoma Atractylodis, 15 parts in Radix Glycyrrhizae.
6. a kind of lotion for the treatment of facial eczema according to claim 1 is characterized in that, is to be made by the crude drug of following weight portion: 30 parts of Radix Sophorae Flavescentiss, 20 parts of Flos Loniceraes, 30 parts of the Rhizoma Anemarrhenaes, 10 parts of Flos Chrysanthemis, 20 parts of Radix Curcumaes, 10 parts on Flos Carthami, 15 parts of Rhizoma Atractylodis, 5 parts in Radix Glycyrrhizae.
7. a kind of preparation method for the treatment of the lotion of facial eczema claimed in claim 1 is characterized in that: after each crude drug is mixed, add water to submerge, decoct 30～60min, remove by filter medicinal residues, and get final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110294088 CN102335390B (en) | 2011-09-30 | 2011-09-30 | Lotion for treating facial eczema |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110294088 CN102335390B (en) | 2011-09-30 | 2011-09-30 | Lotion for treating facial eczema |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102335390A CN102335390A (en) | 2012-02-01 |
| CN102335390B true CN102335390B (en) | 2013-01-02 |
Family
ID=45511490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110294088 Expired - Fee Related CN102335390B (en) | 2011-09-30 | 2011-09-30 | Lotion for treating facial eczema |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102335390B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1172674C (en) * | 1997-11-10 | 2004-10-27 | 赛勒吉药物股份有限公司 | Penetration enhancing and irritation reducing systems |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1056531C (en) * | 1997-08-29 | 2000-09-20 | 刘进成 | Chinese medicinal herb composition for treating skin disease |
-
2011
- 2011-09-30 CN CN 201110294088 patent/CN102335390B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1172674C (en) * | 1997-11-10 | 2004-10-27 | 赛勒吉药物股份有限公司 | Penetration enhancing and irritation reducing systems |
Non-Patent Citations (4)
| Title |
|---|
| 徐明德等.治疗湿疹之我见.《山东中医杂志》.1996,第15卷(第4期), |
| 慢性湿疹的难治性及其相关的临床与实验研究;朱明芳;《中国优秀博士论文集》;20071231;全文 * |
| 朱明芳.慢性湿疹的难治性及其相关的临床与实验研究.《中国优秀博士论文集》.2007, |
| 治疗湿疹之我见;徐明德等;《山东中医杂志》;19961231;第15卷(第4期);全文 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102335390A (en) | 2012-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103230493B (en) | Traditional Chinese medicine composition for treating unhealed wound | |
| CN105770275A (en) | Paste for removing blood stasis and necrotic and promoting granulation and paste preparation method | |
| CN103272041A (en) | Traditional Chinese medicine composition for treating haemorrhoids | |
| CN101347531B (en) | External-use medical ointment for burn and scald | |
| CN104116763A (en) | Taxus chinensis itching eliminating and relieving product and preparation method thereof | |
| CN100339120C (en) | External applied medicine for treating prickly heat | |
| CN103977113B (en) | A kind of Chinese medicine for the treatment of diabetic foot | |
| CN102335390B (en) | Lotion for treating facial eczema | |
| CN102247504B (en) | Method for preparing wart eliminating powder | |
| CN102755577B (en) | Traditional Chinese medicine lotion for treating pruritus vulvae | |
| CN104208295A (en) | Medicine for treating scalds | |
| CN103845591A (en) | External medicinal powder for nursing local induration of vascular access for hemodialysis patients | |
| CN101229263B (en) | Chinese traditional medicine for treating dermatosises | |
| CN101244213A (en) | Externally used Chinese medicinal herb for treating decubitus | |
| CN103446363B (en) | Application compress for the treatment of hemorrhoid and preparation method thereof | |
| CN109646512A (en) | A kind of external medicine composition for promoting chronic wound to heal | |
| CN103301312B (en) | Fumigation-washing care solution for treating perianal eczema and application thereof | |
| CN102258589B (en) | Deer blood medicinal wine for treating rheumatoid arthritis | |
| CN102423419B (en) | External traditional Chinese preparation for treating bedsore | |
| CN102178851B (en) | Medicament for treating nervous headache | |
| CN102406697B (en) | Chinese medicine composite for promoting wound healing after operation | |
| CN101380345B (en) | Multifunctional medicinal wine for mainly treating rheumatism disease and production method thereof | |
| CN102397502A (en) | Preparation method of traditional Chinese medicine preparation for preventing and treating leucoderma | |
| CN101559185A (en) | External medicament for curing varicose vein of lower limbs | |
| CN105663753A (en) | Compound rhizoma coptidis ointment and method for preparing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: WANG WEI Free format text: FORMER OWNER: ZHAO HONGYU Effective date: 20121119 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wang Wei Inventor after: Li Yalin Inventor after: Ma Zhenshen Inventor after: Jin Mengmin Inventor after: Wang Feng Inventor after: Wang Tian Inventor before: Zhao Hongyu |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250031 JINAN, SHANDONG PROVINCE TO: 250014 JINAN, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: ZHAO HONGYU TO: WANG WEI LI YALIN MA ZHENSHEN JIN MENGMIN WANG FENG WANG TIAN |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20121119 Address after: 250014 Ji'nan Province, Lixia District, Shandong by Road No. ten, No. 16766 Applicant after: Wang Wei Address before: 250031 No. 23 normal road, Tianqiao District, Shandong, Ji'nan Applicant before: Zhao Hongyu |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130102 Termination date: 20130930 |